BRISTOL MYERS SQUIBB CO
BMY
DELAYED 1 MONTH
17 insider filings · Latest: Jun 3, 2026
Common Stock Transactions
No transactions found.
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Jun 3, 2026 | Jun 5 8:10 PM | Bartie Wendy ShortEVP, Corporate Affairs | Option Exercise | 8,040 | — | 8,040(D) | View → |
| May 1, 2026 | May 5 9:11 PM | Adam LenkowskyEVP, Chief Commercial Officer | Option Exercise | 1,373 | — | 1,375(D) | View → |
| Mar 10, 2026 | Mar 12 8:24 PM | Benjamin HickeyPresident, RayzeBio Org. | Grant/Award | 28,572 | — | 17,143(D) | View → |
| Mar 10, 2026 | Mar 12 8:23 PM | Hiroshi Chris ShibutaniEVP, Chief Strategy Officer | Grant/Award | 19,592 | — | 11,755(D) | View → |
| Mar 10, 2026 | Mar 12 8:23 PM | Cristian MassacesiEVP,Chief Med Offr,Head of Dev | Grant/Award | 65,306 | — | 39,184(D) | View → |
| Mar 10, 2026 | Mar 12 8:22 PM | Bartie Wendy ShortEVP, Corporate Affairs | Grant/Award | 16,327 | — | 9,796(D) | View → |
| Mar 10, 2026 | Mar 12 8:22 PM | Bartie Wendy ShortEVP, Corporate Affairs | Option Exercise | 5,883 | — | 0(D) | View → |
| Mar 10, 2026 | Mar 12 8:21 PM | Karin ShanahanEVP, Chief Supply Chain & Ops | Grant/Award | 53,061 | — | 31,837(D) | View → |
| Mar 10, 2026 | Mar 12 8:21 PM | Karin ShanahanEVP, Chief Supply Chain & Ops | Option Exercise | 25,501 | — | 0(D) | View → |
| Mar 10, 2026 | Mar 12 8:20 PM | Robert M PlengeEVP, Chief Research Officer | Grant/Award | 44,898 | — | 26,939(D) | View → |
| Mar 10, 2026 | Mar 12 8:20 PM | Robert M PlengeEVP, Chief Research Officer | Option Exercise | 17,501 | — | 0(D) | View → |
| Mar 10, 2026 | Mar 12 8:19 PM | Gregory Scott MeyersEVP, Chief Digital & Tech Off. | Grant/Award | 65,306 | — | 39,184(D) | View → |
| Mar 10, 2026 | Mar 12 8:19 PM | Gregory Scott MeyersEVP, Chief Digital & Tech Off. | Option Exercise | 25,892 | — | 0(D) | View → |
| Mar 10, 2026 | Mar 12 8:18 PM | Adam LenkowskyEVP, Chief Commercial Officer | Grant/Award | 81,633 | — | 48,980(D) | View → |
| Mar 10, 2026 | Mar 12 8:18 PM | Adam LenkowskyEVP, Chief Commercial Officer | Option Exercise | 24,071 | — | 0(D) | View → |
| Mar 10, 2026 | Mar 12 8:17 PM | Phil M HolzerSVP and Controller | Grant/Award | 12,578 | — | 7,547(D) | View → |
| Mar 10, 2026 | Mar 12 8:17 PM | Phil M HolzerSVP and Controller | Option Exercise | 6,191 | — | 0(D) | View → |
| Mar 10, 2026 | Mar 12 8:17 PM | Lynelle HochPresident, Cell Therapy Org. | Grant/Award | 16,327 | — | 9,796(D) | View → |
| Mar 10, 2026 | Mar 12 8:17 PM | Lynelle HochPresident, Cell Therapy Org. | Option Exercise | 8,192 | — | 0(D) | View → |
| Mar 10, 2026 | Mar 12 8:16 PM | Cari GallmanEVP, General Counsel | Grant/Award | 65,306 | — | 39,184(D) | View → |
Page 1 of 2
Next →